During the past decade, Puerto Rico Clinical and Translational Research Consortium conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Puerto Rico Clinical and Translational Research Consortium" #1 sponsor was "Inovio Pharmaceuticals" with 2 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored, "Takeda" with 1 trials sponsored, "University of Hawaii" with 1 trials sponsored and "University of Puerto Rico" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Puerto Rico Clinical and Translational Research Consortium" #1 collaborator was "University of Puerto Rico" with 1 trials as a collaborator and "ViiV Healthcare" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Puerto Rico Clinical and Translational Research Consortium" are "Cervical Dysplasia" (2 trials), "Cervical High Grade Squamous Intraepithelial Lesion" (2 trials), "Flavivirus Infections" (2 trials), "HSIL" (2 trials) and "AIDS Dementia Complex" (1 trials). Many other conditions were trialed in "Puerto Rico Clinical and Translational Research Consortium" in a lesser frequency.

Most popular intervention types in "Puerto Rico Clinical and Translational Research Consortium" are "Biological" (5 trials), "Device" (2 trials), "Drug" (2 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "VGX-3100" (2 trials), "VRC-PBSPLA043-00-VP" (2 trials), "CELLECTRA™-5PSP" (1 trials) and "Electroporation (EP)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Puerto Rico Clinical and Translational Research Consortium" are 4 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Puerto Rico Clinical and Translational Research Consortium". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Puerto Rico Clinical and Translational Research Consortium, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Puerto Rico Clinical and Translational Research Consortium, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".